Skip to content

Evaluation of the effect of anesthetic analgesia strategy on gastrointestinal function recovery in Patients undergoing laparoscopic gynecological surgery based on transabdominal gastrointestinal ultrasound: a prospective observational cohort study

Evaluation of the effect of anesthetic analgesia strategy on gastrointestinal function recovery in Patients undergoing laparoscopic gynecological surgery based on transabdominal gastrointestinal ultrasound: a prospective observational cohort study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110797
Enrollment
Unknown
Registered
2025-10-21
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative gastrointestinal dysfunction

Interventions

Observational group (Propofol + Opioid Sparing):None
Observational group (Remimazolam + Opioid Sparing ):None
Observational group (Esketamine + Opioid Sparing):None

Sponsors

First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.ASA I-III; 2. Age 18-85; 3. Undergo laparoscopic gynecological surgery under general anesthesia; 4. Sign an informed consent form for the observation study.

Exclusion criteria

Exclusion criteria: 1.Severe liver and kidney diseases (history of liver disease, bilirubin level greater than 3.0mg.dl^-1; aspartate aminotransferase Enzyme/alanine aminotransferase greater than 2.5 times the upper limit; serum creatinine level greater than 2mg.dl^-1); 2. Poor control of hypertension (multiple episodes of systolic blood pressure greater than 160mmHg in the hospital ward); 3. Poorly controlled diabetes (preoperative HbA1c level greater than 9%); 4. Benzodiazepines/GABA-A receptor agonists/inhalation anesthetics/flurbiprofen ester/isocloamide Keto intolerance or allergy; 5. Preoperative diagnosis of neuropsychiatric diseases such as anxiety disorder, bipolar disorder, depression, schizophrenia; 6. Pregnant or lactating; 7. Postoperative treatment should be transferred to ICU; 8. Severe gastrointestinal, pancreatic and biliary diseases (gastric reflux, gastric ulcer, bile reflux have been diagnosed before surgery Diseases, chronic constipation, inflammatory bowel disease, irritable bowel syndrome, etc.) and need medical intervention; 9. Satisfactory gastric antrum ultrasound images could not be obtained due to upper abdominal wound, obesity or abdominal distension before surgery; 10. It is expected that gastrointestinal surgery (intestinal resection and anastomosis, appendectomy, enterostomy, etc.) will be performed simultaneously during the operation. 11. The operation is expected to take more than 6 hours or end after 16:00 on the day of the operation.

Design outcomes

Primary

MeasureTime frame
Gastric antral contraction frequency;

Secondary

MeasureTime frame
Gastric antral contraction amplitude;Gastric volume;Motility index;Total bowel sound within 3 minutes;Time to first passage of flatus;Time to first passage of formed stool;Time to first intake of solid food;Total equivalent oral morphine dose of opioid analgesics within 72 hours postoperatively, number of rescue antiemetic doses, and number of laxative doses used.;Pittsburgh Sleep Quality Index scores at 3 days postoperatively, and NRS pain scores at rest and during activity.;Length of postoperative hospital stay;Admission to ICU;Requirement for reoperation;Occurrence of other surgical complications;Ultrasound-based Assessment of Gastrointestinal Injury Score (AGIUS);

Countries

China

Contacts

Public ContactHe Qiulan

First Affiliated Hospital of Sun Yat-sen University

heqiulan@mail.sysu.edu.cn+86 135 7049 5107

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026